.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for addition of people along with MASLD and dimension of liver outcomes in cardio-- renal-- metabolic tests, when information suggest mechanistically possible perks and also clinical safety-- and summarizes points to consider for test style and governing commendation.